Evidence map›Paper›PMID 24339790›Full record

ArticlePLoS genetics2013

Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in Drosophila.

Stanley M Walls, Steve J Attle, Gregory B Brulte, Marlena L Walls, Kim D Finley, Dale A Chatfield, Deron R Herr, Greg L Harris

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Sphingolipids in obesity and related complications.Frontiers in bioscience (Landmark edition) · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Stanley M WallsDepartment of Biology and Molecular Biology Institute, San Diego State University, San Diego, California, United States of America.
Steve J Attle
Gregory B Brulte
Marlena L Walls
Kim D Finley
Dale A Chatfield
Deron R Herr
Greg L Harris
San Diego State University · USNational University of Singapore · SG

Funding

Age-dependent regulation of clearance and signaling pathwaysR01AG039628 · NIA · SAN DIEGO STATE UNIVERSITY · PI FINLEY, KIM D. · 2011 to 2015
$1.5M
Genetic analysis of sphingolipid metabolism and obesityR21HL080811 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI HARRIS, GREG L · 2004 to 2005
$412k
NHLBI NIH HHS 5R21HL80811NHLBI NIH HHS R21 HL080811NIA NIH HHS R01 AG039628NIA NIH HHS R01AG09628
6 · The paper itself

Abstract

Obesity is defined by excessive lipid accumulation. However, the active mechanistic roles that lipids play in its progression are not understood. Accumulation of ceramide, the metabolic hub of sphingolipid metabolism, has been associated with metabolic syndrome and obesity in humans and model systems. Here, we use Drosophila genetic manipulations to cause accumulation or depletion of ceramide and sphingosine-1-phosphate (S1P) intermediates. Sphingolipidomic profiles were characterized across mutants for various sphingolipid metabolic genes using liquid chromatography electrospray ionization tandem mass spectroscopy. Biochemical assays and microscopy were used to assess classic hallmarks of obesity including elevated fat stores, increased body weight, resistance to starvation induced death, increased adiposity, and fat cell hypertrophy. Multiple behavioral assays were used to assess appetite, caloric intake, meal size and meal frequency. Additionally, we utilized DNA microarrays to profile differential gene expression between these flies, which mapped to changes in lipid metabolic pathways. Our results show that accumulation of ceramides is sufficient to induce obesity phenotypes by two distinct mechanisms: 1) Dihydroceramide (C14:0) and ceramide diene (C14:2) accumulation lowered fat store mobilization by reducing adipokinetic hormone- producing cell functionality and 2) Modulating the S1P: ceramide (C14:1) ratio suppressed postprandial satiety via the hindgut-specific neuropeptide like receptor dNepYr, resulting in caloric intake-dependent obesity.

Indexed as

Adipose TissueAdiposityAnimalsAppetiteCeramidesChromatography, LiquidDisease Models, AnimalDrosophila melanogasterEnergy IntakeHumansLysophospholipidsMetabolic SyndromeMutationObesityOligonucleotide Array Sequence AnalysisSpectrometry, Mass, Electrospray IonizationCeramidesLysophospholipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID24339790
PMCPMC3854795
OpenAlexW2011886578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.